Company
Headquarters: London, United Kingdom
Employees: 1,897
CEO: Mr. Kenneth Wilson
£678.0 Million
GBP as of Jan. 1, 2025
US$850.9 Million
Company | Market Cap (USD) |
---|---|
Nike | $109.88 B |
adidas AG | $45.97 B |
Deckers Outdoor Corporation | $33.21 B |
ASICS Corp | $14.07 B |
Skechers U.S.A., Inc. | $11.41 B |
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Last Financial Reports Date | Sept. 30, 2023 |
Revenue TTM | £977.5 M |
EBITDA | £238.9 M |
Gross Profit TTM | £618.1 M |
Profit Margin | 10.56% |
Operating Margin | 10.18% |
Quarterly Revenue Growth | -5.40% |
Dr. Martens plc has the following listings and related stock indices.
Stock: LSE: DOCS wb_incandescent
Stock: FSX: 3U2 wb_incandescent
Stock: OTC: DOCMF wb_incandescent